Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Income tax benefit recognized for stock-based by Year
Income tax benefit (provision) recognized for stock-based compensation ($M) ($M)
Vertex Pharmaceuticals Income tax benefit recognized for stock-based: $129M in FY2025, down 48.9% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Note (Stock-based Compensation).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Income tax benefit (provision) recognized for stock-based compensation ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 129 | -48.9% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 252 | +50.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 168 | +16.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 144 | +73.8% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | 82.9 | -43.6% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 147 | +18.4% | Form 10-K (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 124 | – | Form 10-K (filed 2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 0 | – | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | 0 | – | Form 10-K (filed 2020-02-13) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Income tax benefit recognized for stock-based ($M), annual FY2017–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-tax-ben
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.